Article
GOT1 inhibits hepatocellular carcinoma progression by regulating SLC25A5-dependent mitochondrial apoptosis
2025-09-18
Abstract excerpt
<title>Abstract</title> <p>Hepatocellular carcinoma (HCC) is the most common subtype of primary liver cancer and carries a poor prognosis, with most patients diagnosed at advanced stages that are unresectable and resistant to targeted therapies. Thus, the identification of novel therapeutic targets remains urgently needed. In this study, we investigated the role of glutamate-oxaloacetate transaminase 1 (GOT1) in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8ac940f6-6169-50fa-9a75-4fc02e4d20ba
- DOI
- 10.21203/rs.3.rs-7570221/v1
